00000000nam 2200000zi 4500
0019.913490
003CaOODSP
00520221107182814
006m     o  d f      
007cr cn|||||||||
008220718t20222022onc     obs  f000 0 eng d
020 |a9780660446226
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH82-54/2022E-PDF
24500|aDrug shortages in Canada and their impact on public drug plans, 2017/18 to 2019/20.
264 1|aOttawa, ON : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |c2022.
264 4|c©2022
300 |a1 online resource (45 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Les pénuries de médicaments au Canada et leurs répercussions sur les régimes publics d'assurance-médicaments de 2017-2018 à 2019-2020.
500 |aIssued also in HTML format.
500 |aIncorrect catalogue number (H28-54/2022E-PDF) printed in this publication.
504 |aIncludes bibliographical references.
650 0|aPharmaceutical services insurance|zCanada.
650 0|aDrug accessibility|zCanada.
650 0|aDrugs|xSupply and demand|zCanada.
7101 |aCanada. |bPatented Medicine Prices Review Board, |eissuing body.
77508|tLes pénuries de médicaments au Canada et leurs répercussions sur les régimes publics d'assurance-médicaments de 2017-2018 à 2019-2020.|w(CaOODSP)9.913491
85640|qPDF|s710 MB|uhttps://publications.gc.ca/collections/collection_2022/cepmb-pmprb/H82-54-2022-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/drug-shortages-impact.html